Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.

Locally applied topical nitrates effective for Raynaud’s phenomenon

26 May 2018

Locally applied topical nitrates appear to be significantly effective in the treatment of primary and secondary Raynaud’s phenomenon (RP), according to a recent meta-analysis.

Pooled analysis from seven studies showed that topical nitrates had a significant moderate-to-large treatment effect on RP relative to placebo (standardized mean difference [SMD], 0.70; 95 percent CI, 0.36–1.05; p=0.00006). Significant heterogeneity was observed in this dataset.

Subsequent subgroup analyses showed that this effect was more pronounced in secondary (SMD, 0.95; 0.25–1.65; p=0.008) than in primary (SMD, 0.45; 0.05–0.85; p=0.0e) RP, but nevertheless remained significant in both cases. The secondary, but not the primary, RP group showed significant heterogeneity.

A post-hoc random effects meta-regression analysis used MQX-503, an alternative nitroglycerin gel vehicle, as a covariate and showed that it accounted for 73 percent of the heterogeneity in the main study group and 100 percent of the heterogeneity in the secondary RP subgroup.

MQX-503 yielded smaller effect sizes in the main study group (SMD, 0.36; 0.13–0.60; p=0.05) and secondary RP subgroup (SMD, 0.38; 0.09–0.67; p=0.01). This may be due to the different efficacies of the vehicle or the variations in trial designs, said researchers.

“Future comparative clinical trials may clarify whether differences between vehicles are attributable to a lower relative efficacy of MQX-503 vehicle or other factors,” they added.

For the present meta-analysis, researchers accessed the databases of the Cochrane library, Embase and Medline for trials that compared the efficacy of locally applied topical nitrates with placebo for RP. Efficacy was measured as subjective clinical improvements or objective improvement in digital blood flow.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.